Is Non-Celiac Gluten Sensitivity Real?

FRIDAY, July 29, 2016, (HealthDay News) -- Gluten sensitivity appears to be a real medical problem, and not a figment of the popular imagination conjured up by the gluten-free craze, a new study contends.

Sharing Drug 'Snorting Straws' Spreads Hepatitis C

WEDNESDAY, July 27, 2016 (HealthDay News) -- Sharing straws to snort opioids is a major cause of hepatitis C infection, a new study finds.

Omega-3s in Fish Tied to Better Colon Cancer Outcomes

THURSDAY, July 21, 2016 (HealthDay News) -- Colon cancer patients who take in higher amounts of omega-3 fatty acids, mainly from oily fish, may have better odds of survival, a new study finds.

Cutting Down on Sweets Can Help Kids' Hearts

TUESDAY, July 19, 2016 (HealthDay News) -- Cutting sugar -- not calories -- is the key to reducing the risk of heart disease among obese children, a new study suggests.

Gut Bacteria May Hold Clues to Chronic Fatigue Syndrome

FRIDAY, July 15, 2016 (HealthDay News) -- Chronic fatigue syndrome -- a condition that continues to baffle doctors -- may be influenced by a person's intestinal bacteria -- sometimes called gut microbiome, new research finds.

Headed to the Pool? Protect Yourself From the Poop

SATURDAY, July 9, 2016 (HealthDay News) -- Swimming is a great way to cool off on a hot day, but beware of fecal contamination that can make you sick, an expert says.

Could Statins Help Fight Cancer?

FRIDAY, July 8, 2016 (HealthDay News) -- Some cancer patients who take cholesterol-lowering statins may live longer than those not on these heart medications, a study from Britain suggests.

Researchers Get Closer to Test Predicting Colon Cancer's Return

THURSDAY, July 7, 2016 (HealthDay News) -- A blood test that detects bits of DNA shed from colon cancers may someday help doctors predict a relapse, researchers report.

Regular Doctor Visits Can Help Spot Colon Cancer

MONDAY, July 4, 2016 (HealthDay News) -- Making regular visits to a primary care doctor increases the odds you'll be screened for colon cancer, a new study says.

Epclusa Approved for Chronic Hepatitis C

TUESDAY, June 28, 2016 (HealthDay News) -- The combination drug Epclusa has been approved by the U.S. Food and Drug Administration to treat the six major strains of chronic hepatitis C virus (HCV).